NYSE · Healthcare · Medical - Devices
Price at previous close. Open the live page for real-time data.
| Market cap | $153.59B |
| P/E ratio | 24.545386332058637 |
| P/B ratio | 2.9589682222777127 |
| P/S ratio | 3.403039965436257 |
| Dividend yield | 2.77% |
| Return on equity | — |
| Net margin | 13.9% |
| EPS (TTM) | — |
| Beta | 0.62 |
| 52-week range | $81.97 – $139.06 |
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vacci…
What is Abbott Laboratories's P/E ratio?
Abbott Laboratories's trailing price-to-earnings (P/E) ratio is 24.5.
Does Abbott Laboratories pay a dividend?
Yes — the trailing dividend yield is approximately 2.77%.
What is ABT's market capitalisation?
Abbott Laboratories's market cap is approximately $153.59B.
Educational data only — not financial advice. Figures from Financial Modeling Prep, updated periodically. Verify before acting.